SorCS1 for the treatment of obesity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9387232
SERIAL NO

13327234

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to SorCS1-like agents, including SorCS1, nucleic acid molecule encoding expression of SorCS1 and fragments thereof, as well as vectors containing said nucleic acid and to cells expressing SorCS1 and said fragments, for the treatment of obesity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
KJØLBY MADSKORSHØJEN 83 RISSKOV 8240
NYKJAER ANDERSSKOLEVANGS ALLÉ 1 RISSKOV 8240

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kjolby, Mads Fuglsang Risskov, DK 4 11
Nykjaer, Anders Risskov, DK 19 118
Pedersen, Karen-Marie Tjele, DK 5 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 12, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00